Latest Listings And Ipos News

Green & Gold Minerals has successfully listed on the ASX, raising $5.7 million to fund drilling at its Chillagoe Gold Project, with initial results expected soon. The company also holds promising critical minerals prospects in Queensland.

DeSoto Resources has reported compelling high-grade gold intercepts in Guinea’s Siguiri Basin alongside a $14 million capital raise and a strategic joint venture to accelerate exploration.

Trigg Minerals has initiated the process for a Nasdaq dual listing via an American Depositary Receipt program, aiming to tap into the world’s largest capital market. The company also raised A$2.5 million from Tribeca Investment Partners, reinforcing its growth strategy.

Wingara AG reports a modest cash position of $302,000 as it winds down processing operations and seeks fresh transaction opportunities following the termination of its TerraFirma deal.

Impact Minerals Limited reported a net cash outflow in operating and investing activities for Q3 2025 but strengthened its cash position through a significant equity raise, ending the quarter with nearly $5 million in cash.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

Lightning Minerals has launched its inaugural drilling campaign at the Mt Turner gold and silver project in Queensland, backed by a fresh A$2 million capital raise. Meanwhile, exploration advances across its lithium assets in Brazil signal a multi-commodity growth strategy.

Harmoney Corp Limited has reaffirmed its FY26 profit guidance of $12 million Cash NPAT, driven by strong loan book growth and the launch of a secured vehicle loan product leveraging its Stellare 2.0 platform.

MRG Metals secures the Corridor South mining licence, completing key permits for its massive 2-billion-tonne heavy mineral sands project, while setting ambitious production goals and expanding rare earth exploration.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Emerald Resources NL reports steady gold output at its Okvau Gold Mine alongside significant resource upgrades at its Dingo Range and Memot projects, underpinning a robust growth trajectory.

Kingston Resources Limited reported a robust cash position of A$31 million at the end of September 2025, supported by significant investing inflows and prudent financing activity.